Eazymed Technologies Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 4.46 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 210.09%
- Profit Growth -131.34%
- Ebitda -313.08%
- Net Worth -327.42%
- Total Assets 150.90%
About Eazymed Technologies
Eazymed Technologies Private Limited (ETPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 August 2020 (Four years and five months 21 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.46 M, as per Ministry of Corporate Affairs (MCA) records.
Saurab Jain and Devashish Singh serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U51909TN2020PTC137231
-
Company No.
137231
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Aug 2020
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Eazymed Technologies Private Limited offer?
Eazymed Technologies Private Limited offers a wide range of products and services, including Immunization, Rabies Serum, Cardiovascular Drugs, Deflux Injection, Gastrointestinal Drugs, Gastrointestinal Injection, Anti Rabies Immunoglobulins, Pain Relief Drugs, Bonmax Injection, Bonista Injection.
Who are the key members and board of directors at Eazymed Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devashish Singh
|
Director | 31-Oct-2020 | Current |
|
Saurab Jain
|
Director | 20-Aug-2020 | Current |
Financial Performance of Eazymed Technologies.
Eazymed Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 210.09% increase. The company also saw a substantial fall in profitability, with a 131.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 327.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eazymed Technologies?
Unlock access to Eazymed Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Remedi Speciality Medicines LlpSaurab Jain is a mutual person
-
Autofluid Technologies Llp
Saurab Jain is a mutual person
-
Adzz Learning Llp
Devashish Singh is a mutual person
-
Silverline Investment And Finance Private Limited
Devashish Singh is a mutual person
-
Greatest Common Factor Private Limited
Devashish Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eazymed Technologies?
Eazymed Technologies has a workforce of 47 employees as of May 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eazymed Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eazymed Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
